Early Access — free while we kick the tires
EdgarHawk

ROHRS THOMAS M

Director

Director
2 filings analyzed · 1 company · Latest 2026-02-12

Companies

Company Buys Sells Direction
ICHOR HOLDINGS, LTD. ICHR 0 6 Net selling

Activity

February 2026
2026-02-12 ICHOR HOLDINGS, LTD. ICHR
high
Sell
53,908 shares
$2,451,736
Significance 8/10

Director Rohrs sells 53.9K shares (50.4% of holdings) at $45.48; prior 4 sells at ICHR all well-timed, stock +68.1% 30d but unprofitable.

Thomas M. Rohrs, a director, divested exactly half his ICHR position, selling 53,908 shares at $45.48 on 2026-02-12, leaving him with 53,024 shares. His prior four sales at this same ticker (2025, 2024, 2023) were all well-timed at the 90-day mark, with post-sale declines ranging from -16.0% to -44.8%. The company is currently unprofitable (net income $-22,853,000.00 for the latest full year) and reported net losses of $-22,853,000.00 in the most recent quarter. The stock has surged +68.1% over the past 30 days and +200.1% over 90 days—well above its 52-week high of $47.59 by the transaction date, placing the sale at a notably elevated price level. Rohrs' historical pattern of well-timed exits at this ticker (100% success rate across 4 prior trades) combined with the aggressive recent rally into an unprofitable business suggests the market may have priced in optimism that warrants investor scrutiny.

February 2025
2025-02-19 ICHOR HOLDINGS, LTD. ICHR
high
Sell
125,000 shares
$4,014,843
Significance 7/10

Director Thomas M. Rohrs sold 125,000 ICHR shares for $4.0M at $32.12 avg; holds 47,687 post-sale (-72.4%)

Director Thomas M. Rohrs executed 2 separate sales totaling 125,000 shares for $4,014,842.64, reducing his stake by 72.4% from 172,687 shares to 47,687 shares at a blended average price of $32.12. His prior trades at ICHR show a consistent pattern: both his 2024-02-16 and 2023-08-31 sales were followed by declines over the 90-day period (−16.0% and −27.8%, respectively), with 2 of 2 prior sells at this ticker well-timed. Against this backdrop, the sale occurs while ICHR trades at $35.08 (−22.9% from its 52-week high) and the company reported negative earnings (−$2.8M net income) and severe annual revenue contraction (−36.6%). The magnitude of this reduction in holdings, combined with the director's established track record of well-timed exits at this ticker and the company's deteriorating financial position, signals a material reduction in insider commitment to the stock.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access